IRCT20200407046981N12尚未招募未知
Randomized, single-dose, crossover comparative bioequivalence study of the Esomeprazole 10mg sachet produced by Razan Pharmed Iranian pharmaceutical Co versus Nexium® (AstraZeneca company) in 24 healthy males under fasting conditions
???? ???????? ????? ????? ????????0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •The weight limit for each volunteer is between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Esomeprazole or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Regular smoker who smokes more than ten cigarettes daily.
- •Taking any medicine during two week before dosing.
研究者
相似试验
已完成
不适用
Bioequivalence study of Metoprolol succinate 95 mg ER tablets in 24 healthy male under fasting conditionsIRCT20180620040164N11Actover pharmaceutical co.24
已完成
不适用
bioequivalence study of Metformin 100 mg + Sitagliptin 50 mg tablets in 24 healthy male under fasting conditionsIRCT20180620040164N15Actover co24
已完成
不适用
Bioequivalence study of zolpidem 10 mg tablet in 24 healthy male under fasting conditionscomparative bioequivalence study of zolpidem 10 mg tablets of Marhamdarou Co. and Sanofi Co..IRCT20180620040164N1Marham daru24
招募中
不适用
Study of absorption and elimination rate of Atorvastatin 40 mg tablets in comparison with standard tablets of Atorvastatin (Lipitor®).Bioequivalence study.IRCT20200407046981N16Daana pharmaceutical company24
招募中
Unknown
bioequivalence study of Gliclazide 30 mg MR tablet in 24 healthy male under fasting conditionsdiabetes mellitus.Type 1 diabetes mellitusIRCT20180620040164N53ACtover Pharmaceutical Co.24